Healthcare biotech is a diverse sector, with 2,000 companies in Europe ranging from large multinational enterprises – with global annual sales exceeding €10 billion and annual research and development (R&D) expenditures of €1-€4 billion – to much smaller enterprises with fewer than ten employees and only grant-based income. It also includes hundreds of thousands of talented researchers, doctors and healthcare workers – all striving to push the frontiers of medical know-how.
To stimulate the discussion, we will be joined by two of the sector’s stars, Edwin Moses, CEO of Ablynx of Ghent and Jörn Aldag, CEO of Uniqure of Amsterdam, to hear their stories from the ‘front lines’ of healthcare biotech. We will discuss with them how they got started, what obstacles they had to overcome, and what policy prescriptions their experiences might suggest. Other featured guests include Didier Schmitt, Scientific Adviser & Foresight Coordinator, European Commission and Rudolf Strohmeier, Deputy Director General, DG Research and Innovation, European Commission.
This event is by invitation only. Please contact firstname.lastname@example.org if you are interested in participating.
18:30 - Welcome & introduction by Richard L. Hudson, CEO & Editor, Science|Business
18:35 - Europe’s Healthcare Biotech Stars
- Case study I: Jörn Aldag, uniQure, on better, faster procedures for getting new
medicines to market
- Case study II: Edwin Moses, Ablynx, on the biotech healthcare value chain
18:55 - Moderated discussion
- Dainius Pavalkis, Minister of Education and Science of the Republic of Lithuania
- Rudolf Strohmeier, Deputy Director-General, DG RTD, European Commission
- Emmanuel Chantelot, Chairman of EuropaBio’s Healthcare Biotechnology Council
Moderator: Richard L. Hudson, CEO & Editor, Science|Business
19:30 - Dinner debate
- Richard L. Hudson, CEO & Editor, Science|Business
- Nathalie Moll, Secretary General, EuropaBio
Opening statements: The view from the Parliament:
- Vicky Ford, Member, European Parliament
- Philippe De Backer, Member, European Parliament